LIfT BioSciences Announces CEO Transition to Drive Next Phase of Growth with Neutrophil-based Therapies
Dr. Bo Rode Hansen, current Board member and Corporate Development Officer named Interim CEO Alex Blyth, Founder and CEO to step down and will continue to work with the Company at a Board level LIfT BioSciences is currently advancing its first IMAN-based …